Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Net Income (2016 - 2025)

Historic Net Income for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to $3.7 billion.

  • Gsk's Net Income rose 446187.52% to $3.7 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $9.7 billion, marking a year-over-year increase of 1210.01%. This contributed to the annual value of $13.2 billion for FY2022, which is 50915.79% up from last year.
  • Per Gsk's latest filing, its Net Income stood at $3.7 billion for Q3 2025, which was up 446187.52% from $2.8 billion recorded in Q2 2025.
  • In the past 5 years, Gsk's Net Income registered a high of $11.9 billion during Q3 2022, and its lowest value of $81.9 million during Q3 2024.
  • For the 5-year period, Gsk's Net Income averaged around $2.5 billion, with its median value being $2.1 billion (2024).
  • Per our database at Business Quant, Gsk's Net Income crashed by 9684.46% in 2024 and then surged by 446187.52% in 2025.
  • Over the past 5 years, Gsk's Net Income (Quarter) stood at $687.5 million in 2021, then increased by 6.63% to $733.1 million in 2022, then soared by 687.27% to $5.8 billion in 2023, then fell by 24.92% to $4.3 billion in 2024, then fell by 13.82% to $3.7 billion in 2025.
  • Its Net Income stands at $3.7 billion for Q3 2025, versus $2.8 billion for Q2 2025 and $3.1 billion for Q1 2025.